References
- Felt O, Buri P, Gurny R. Chitosan: a unique polysaccharide for drug delivery. Drug Dev Ind Pharm 1998;24:979–993
- Hirano S. Chitin and chitosan as novel biotechnological materials. Polym Int 1999;48:732–734
- Pillai CKS, Paul W, Sharma CP. Chitin and chitosan polymers: chemistry, solubility and fiber formation. Prog Polym Sci 2009;34:641–678
- Singla AK, Chawla M. Chitosan: some pharmaceutical and biological aspects – an update. J Pharm Pharmacol 2001;53:1047–1067
- Liu LS, Liu SQ, Ng SY, et al. Controlled release of interleukin-2 for tumour immunotherapy using alginate/chitosan porous microspheres. J Control Release 1997;43:65–74
- Polk A, Amsden B, De Yao K, et al. Controlled release of albumin from chitosan-alginate microcapsules. J Pharm Sci 1994;83:178–185
- Brockway WJ, Castellino FJ. Characterization of native streptokinase and altered streptokinase isolated from a human plasminogen activator complex. Biochemistry 1974;13:2063–2070
- Wu XC, Ye R, Duan Y, Wong SL. Engineering of plasmin-resistant forms of streptokinase and their production in Bacillus subtilis: streptokinase with longer functional half-life. Appl Environ Microbiol 1998;64:824–829
- Shi GY, Chang BI, Su SW, et al. Preparation of a novel streptokinase mutant with improved stability. Thromb Haemost 1998;79:992–997
- Torrens I, Ojalvo AG, Seralena A, et al. A mutant streptokinase lacking the C-terminal 42 amino acids is less immunogenic. Immunol Lett 2000;70:213–218
- Rajagopalan S, Gonias SL, Pizzo SV. A nonantigenic covalent streptokinase--polyethylene glycol complex with plasminogen activator function. J Clin Investig 1985;75:413--419
- Leach JK, O‘Rear EA, Patterson E, et al. Accelerated thrombolysis in a rabbit model of carotid artery thrombosis with liposome-encapsulated and microencapsulated streptokinase. Thromb Haemost 2003;90:64–70
- Kim IS, Choi HG, Choi HS, et al. Prolonged systemic delivery of streptokinase using liposome. Arch Pharm Res 1998;21:248–252
- Nguyen PD, O’Rear EA, Johnson AE, et al. Accelerated thrombolysis and reperfusion in a canine model of myocardial infarction by liposomal encapsulation of streptokinase. Circ Res 1990;66:875–878
- Yang X, Zhang X, Liu Z, et al. High-efficiency loading and controlled release of doxorubicin hydrochloride on graphene oxide. J Phys Chem C 2008;112:17554–17558
- Hans ML, Lowman AM. Biodegradable nanoparticles for drug delivery and targeting. Curr Opin Solid State Mater Sci 2002;6:319–327
- Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein--dye binding. Anal Biochem 1976;72:248–254
- Banerjee A, Chisti Y, Banerjee UC. Streptokinase – a clinically useful thrombolytic agent. Biotechnol Adv 2004;22:287–307
- Wu Y, Yang W, Wang C, et al. Chitosan nanoparticles as a novel delivery system for ammonium glycyrrhizinate. Int J Pharm 2005;295:235–245
- Gan Q, Wang T. Chitosan nanoparticle as protein delivery carrier – systematic examination of fabrication conditions for efficient loading and release. Colloids Surf B Biointerfaces 2007;59:24–34
- Takahashi T, Takayama K, Machida Y, Nagai T. Characteristics of polyion complexes of chitosan with sodium alginate and sodium polyacrylate. Int J Pharm 1990;61:35–41